Formulation of injections Flashcards

1
Q

Parenteral

A
  • injection through skin or mucous membranes
  • sterile drug, solution, suspension packaged by hypodermic injection

SVP - airtight sealed in a container less than 100mL
LVP - more than 100mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Reasons for use of inj

A
Systematic delivery when other routes not available
Direct control ie anaphylaxis
correct rapid electrolyte imbalance
target specific areas
local action (local anaesthetics)
minimise systemic side effects
unconscious patients
uncooperative/ uncontrollable patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Formulation Issues

A
Volume of injection
Solvents
Selection of Vehicle
Types of vehicle
Excipients:
- Buffers
- Antioxidants
-Preservatives
Tonicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Volume of injection

A
  • IV large volume 1-100ml

- IM 3ml, SC 2ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Solvents

A
  • IV, Intraspinal –> dilute aqueous
  • IM, SC –>aqueous, oily, suspension
    Desired properties:
  • inert
  • non-toxic
  • fluid at body temp
  • miscible with body fluids
  • can be sterilised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Selection of vehicle

A

Solubility increase with use of colsolvents, complexing agents, pH manipulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of vehicles

A

Aqueous based e.g. WFI
Water miscible solvents
- glycerol, ethyl alcohol, propylene glycol, glycol 300 400
- inert, mix with body fluids, maybe irritating and toxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Buffers

A
Solubiltiy
Stability
Issues:
- isotonicity
- buffer capacity
- pH change
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antioxidants

A

autoxidation
pH effects: increase pH increase oxidation
chelating agents: catalyse oxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Preservatives:

A

Multi-dose containers
loss into rubber closure
partitioning into non-aq phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tonicity

A

isotonic: same osmotic pressure as blood plasma otherwise painful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Suspension

A

crystal growth, easily resuspendable, particle size
Limitations:
- microbiological purity
- range of ingredients allowed
- mechanical flow properties (injectability)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Emulsions

A

Limitations:

  • autoclaving –> heat stress?
  • pyrogenicity
  • risk of solubilising into container
  • choice of surfactant affects particle size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Powders for injection

A

Advantages:

  • low temp little degradation
  • light and porous
  • no contact with air

Disadvantage:

  • hygroscopic product
  • slow
  • expensive equipment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly